Vanta Bioscience Ltd (VANTABIO) Financials - Quarterly Results, Profit & Loss, Balance Sheet, Cash Flow Vanta Bioscience Ltd reported sales of ₹0.3 Cr, operating profit of ₹-0.37 Cr (OPM -123.33%) and net profit of ₹-1.82 Cr for the quarter ended Sep 2025. Figures in ₹ crore, consolidated where available.
VANTABIO quarterly results (₹ Cr) Metric Mar 2022 Sep 2022 Mar 2023 Sep 2023 Mar 2024 Sep 2024 Mar 2025 Sep 2025 Sales 4.31 2.82 3.45 6.18 3.55 1.03 0.93 0.3 Expenses 2.33 3.37 5.3 4.12 4.3 1.42 4.81 0.67 Operating Profit 1.98 -0.55 -1.85 2.06 -0.75 -0.39 -3.88 -0.37 OPM 45.94% -19.5% -53.62% 33.33% -21.13% -37.86% -417.2% -123.33% Other Income 0.4 0.01 0.68 0.03 0.08 0.04 0.07 0 Interest 1.2 2.48 3.4 2.85 2.9 2.14 1.92 0.88 Depreciation 0.66 1.31 1.36 1.54 2.95 1.69 2.73 0.61 Profit before tax 0.52 -4.33 -5.93 -2.3 -6.52 -4.18 -8.46 -1.86 Tax 13.46% 2.08% 1.52% -0.87% -3.07% -1.2% 8.39% -2.69% Net Profit 0.07 -2.56 -3.92 -0.54 -1.78 -2.07 -2.71 -1.82 EPS in Rs 0.11 -4.06 -6.21 -0.86 -2.82 -3.28 -4.29 -2.56
VANTABIO profit & loss, annual (₹ Cr) Metric Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM Sales 9.82 9.4 5.83 9.72 1.96 1.23 Expenses 5.87 5.93 8.22 8.41 6.21 5.48 Operating Profit 3.95 3.47 -2.39 1.31 -4.25 -4.25 OPM 40.22% 36.91% -40.99% 13.48% -216.84% -345.53% Other Income 0.03 0.42 0.69 0.11 0.11 0.07 Interest 2.14 2.35 5.89 5.75 4.07 2.8 Depreciation 1.25 1.32 2.67 4.5 4.42 3.34 Profit before tax 0.59 0.22 -10.26 -8.83 -12.63 -10.32 Tax 23.73% 40.91% 1.75% -2.49% 5.23% - Net Profit 0.45 0.14 -10.44 -8.61 -13.29 -4.53 EPS in Rs 0.71 0.14 -10.27 -3.68 -7.56 -6.85 Dividend Payout 0% 0% 0% 0% 0% -
VANTABIO balance sheet (₹ Cr) Metric Mar 2022 Mar 2023 Mar 2024 Mar 2025 Sep 2025 Equity Capital 6.31 6.31 6.31 6.31 7.11 Reserves 17.7 11.2 8.89 4.11 12.14 Borrowings 44.86 57.16 60.96 70.09 30.57 Other Liabilities 12.53 10.04 9.24 5.37 7.04 Total Liabilities 81.4 84.71 85.4 85.88 56.86 Fixed Assets 36.12 57.22 54.15 55.5 41.82 CWIP 28.47 10.6 12.53 13.47 0 Investments 0 0 0 0 3 Other Assets 16.81 16.89 18.72 16.91 12.04 Total Assets 81.4 84.71 85.4 85.88 56.86
VANTABIO cash flows (₹ Cr) Metric Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Cash from Operating Activity 6.97 5.28 -0.63 2.68 -2.41 Cash from Investing Activity -22.3 -17.24 -5.91 -3.31 -6.69 Cash from Financing Activity 17.78 9.53 6.41 0.69 9.16 Net Cash Flow 2.46 -2.43 -0.13 0.06 0.06 Free Cash Flow -15.23 -11.9 -6.54 -0.63 -9.1 CFO/OP 176% 152% 26% 205% 57%
VANTABIO ratios Metric Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Debtor Days 74.71 43.88 122.71 117.91 465.56 Inventory Days - - - - 2,400.15 Days Payable - - - - 1,821.31 Cash Conversion Cycle 74.71 43.88 122.71 117.91 1,044.4 Working Capital Days 91.06 -135.13 -163.4 -217.42 -2,126.68 ROCE 5.21% 3.77% -5.82% -4.16% -11.58%